September 2, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Its 6.38% Return on Equity and Market Prospects

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, focusing on the development and commercialization of treatments for central nervous system (CNS) diseases...

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 6.68% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player in the healthcare sector, carving its niche within the drug manufacturing industry focusing on specialty and..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring the 8.74% Upside Potential Amidst Innovative Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a compelling player in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With a market capitalization..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 92% Potential Upside Awaits Investors

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, offering intriguing potential for investors seeking high-growth opportunities in the biotechnology sector. With..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Healthcare Gem with Robust Revenue Growth and Promising Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the medical instruments and supplies industry, and its recent financial performance underscores its potential as a..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a 101% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a pioneering entity in the healthcare sector, has become a focal point of interest for investors seeking exposure to the specialty..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Potential 41.81% Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology firm specializing in neuroscience, has become a focal point for investors seeking significant growth potential. With its current..

Healthcare Services Group, Inc. (HCSG): Investor Outlook and Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a pivotal player in the healthcare sector, offers vital management, administrative, and operational services across the United States. With a..

Evotec SE (EVO): Exploring a 70% Upside Potential in the Drug Discovery Sector

Investors seeking opportunities in the healthcare sector may want to consider Evotec SE (EVO), a leading player in the drug discovery and development industry. With a..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Investment with Robust Revenue Growth

National HealthCare Corporation (NYSE: NHC) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Murfreesboro, Tennessee, NHC operates..

Indivior PLC (INDV) Stock Analysis: Exploring 20% Upside Potential for Investors

Indivior PLC (INDV), a key player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing, has recently caught the attention of..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 109.72% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative RNA medicines platform, PRISM. Based in Singapore, the company is..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a Potential 180% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) presents a compelling opportunity for investors in the biotechnology sector, with a potential upside of 180.70% based on the average target..

Catalyst Pharmaceuticals (CPRX): Analysts See 66% Upside for This Biotech Innovator

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is catching the attention of investors with its promising potential upside. This commercial-stage biopharmaceutical company, headquartered in Coral Gables, Florida, focuses..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 12.21% Potential Upside in the Medical Devices Sector

CONMED Corporation (NYSE: CNMD) stands out in the healthcare sector with its innovative contributions to medical devices, focusing on surgical procedures and orthopedic solutions. With a..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a 35% Potential Upside in Healthcare Innovations

Omnicell, Inc. (OMCL), a key player in the healthcare sector, is drawing investor attention with its innovative medication management solutions and a promising potential upside of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Bold Bet with 262.95% Potential Upside

For investors keen on high-risk, high-reward opportunities, Janux Therapeutics, Inc. (NASDAQ: JANX) might be a compelling consideration. With a staggering potential upside of 262.95%, this clinical-stage..

MiMedx Group, Inc (MDXG) Stock Analysis: Healthcare Innovator with 71.83% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative medical solutions and an enticing potential upside..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 48% Upside in Synthetic DNA Solutions

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a noteworthy potential upside..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO) is catching the attention of savvy investors looking for opportunities in the healthcare sector. With a current market capitalization of $1.28 billion,..

Search

Funds

September 2, 2025

Search

Funds

September 2, 2025

FTSE 100

Funds